| # | Drug | Count |
|---|---|---|
| 0 | CRIZOTINIB | 3 |
| 1 | DOCETAXEL | 3 |
| 2 | DOCETAXEL ANHYDROUS | 3 |
| 3 | GEMCITABINE | 3 |
| 4 | GEMCITABINE HYDROCHLORIDE | 3 |
| 5 | AVELUMAB | 2 |
| 6 | AXITINIB | 2 |
| 7 | BEVACIZUMAB | 2 |
| 8 | CARBOPLATIN | 2 |
| 9 | CISPLATIN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AVELUMAB | 2 | 0.0005 |
| 1 | CRIZOTINIB | 3 | 0.0002 |
| 2 | AXITINIB | 2 | 0.0001 |
| 3 | IFOSFAMIDE FOR INJECTION | 2 | 0.0001 |
| 4 | GOSERELIN | 1 | 0.0001 |
| 5 | CLOBAZAM | 1 | 0.0001 |
| 6 | GEMCITABINE HYDROCHLORIDE | 3 | 0.0001 |
| 7 | SUNITINIB MALATE | 2 | 0.0001 |
| 8 | ABEMACICLIB | 1 | 0.0000 |
| 9 | IPILIMUMAB | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 2 | 0.0000 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 3 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 4 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Microtubule Inhibitor [EPC] | 3 | 0.0000 |
| 6 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Kinase Inhibitor [EPC] | 6 | 0.0000 |
| 9 | Alkylating Drug [EPC] | 2 | 0.0000 |